Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

 

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

2016-01-23 07:38:52| Biotech - Topix.net

Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha Injection, the first proprotein convertase subtilisin/kexin type 9 inhibitor to be approved in Japan. Repatha is a human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol , or "bad" cholesterol, from the blood.

Tags: japan approval injection announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

01.11 Eastern North Pacific Tropical Weather Outlook 01.11 Atlantic Tropical Weather Outlook 01.11 CERM launches new MIS products, Mark Andy innovates and more 01.11 Removing a major trade barrier: Full access to Colombia restored for U.S. beef 01.11 Global BEEF Series: Leveling the playing field on quality beef 01.11 Getting more out of fall and winter grazing 01.11 U.S. Boston butt burger launches in Colombia 01.11 All Americans have a role in keeping African swine fever out More »